User and Usability Testing of a Web-Based Genetics Education Tool for Parkinson Disease: Mixed Methods Study

Overview

Journal JMIR Bioinform Biotechnol

Date 2024 Jun 27

PMID 38935961

Authors

Noah Han

Rachel A Paul

Tanya Bardakjian

Daniel Kargilis

Angela R Bradbury

Alice Chen-Plotkin

Thomas F Tropea

Affiliations

Soon will be listed here.

Abstract

Background: Genetic testing is essential to identify research participants for clinical trials enrolling people with Parkinson disease (PD) carrying a variant in the glucocerebrosidase (GBA) or leucine-rich repeat kinase 2 (LRRK2) genes. The limited availability of professionals trained in neurogenetics or genetic counseling is a major barrier to increased testing. Telehealth solutions to increase access to genetics education can help address issues around counselor availability and offer options to patients and family members.

Objective: As an alternative to pretest genetic counseling, we developed a web-based genetics education tool focused on GBA and LRRK2 testing for PD called the Interactive Multimedia Approach to Genetic Counseling to Inform and Educate in Parkinson's Disease (IMAGINE-PD) and conducted user testing and usability testing. The objective was to conduct user and usability testing to obtain stakeholder feedback to improve IMAGINE-PD.

Methods: Genetic counselors and PD and neurogenetics subject matter experts developed content for IMAGINE-PD specifically focused on GBA and LRRK2 genetic testing. Structured interviews were conducted with 11 movement disorder specialists and 13 patients with PD to evaluate the content of IMAGINE-PD in user testing and with 12 patients with PD to evaluate the usability of a high-fidelity prototype according to the US Department of Health and Human Services Research-Based Web Design & Usability Guidelines. Qualitative data analysis informed changes to create a final version of IMAGINE-PD.

Results: Qualitative data were reviewed by 3 evaluators. Themes were identified from feedback data of movement disorder specialists and patients with PD in user testing in 3 areas: content such as the topics covered, function such as website navigation, and appearance such as pictures and colors. Similarly, qualitative analysis of usability testing feedback identified additional themes in these 3 areas. Key points of feedback were determined by consensus among reviewers considering the importance of the comment and the frequency of similar comments. Refinements were made to IMAGINE-PD based on consensus recommendations by evaluators within each theme at both user testing and usability testing phases to create a final version of IMAGINE-PD.

Conclusions: User testing for content review and usability testing have informed refinements to IMAGINE-PD to develop this focused, genetics education tool for GBA and LRRK2 testing. Comparison of this stakeholder-informed intervention to standard telegenetic counseling approaches is ongoing.

References

Lesage S, Brice A . Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet. 2009; 18(R1):R48-59. DOI: 10.1093/hmg/ddp012. View

Alcalay R, Kehoe C, Shorr E, Battista R, Hall A, Simuni T . Genetic testing for Parkinson disease: current practice, knowledge, and attitudes among US and Canadian movement disorders specialists. Genet Med. 2019; 22(3):574-580. PMC: 7056638. DOI: 10.1038/s41436-019-0684-x. View

Driver M, Kuo S, Petronio L, Brockman D, Dron J, Austin J . Evaluating the impact of a new educational tool on understanding of polygenic risk scores for alcohol use disorder. Front Psychiatry. 2022; 13:1025483. PMC: 9726708. DOI: 10.3389/fpsyt.2022.1025483. View

Gaieski J, Patrick-Miller L, Egleston B, Maxwell K, Walser S, DiGiovanni L . Research participants' experiences with return of genetic research results and preferences for web-based alternatives. Mol Genet Genomic Med. 2019; 7(9):e898. PMC: 6732272. DOI: 10.1002/mgg3.898. View

Tropea T, Amari N, Han N, Rick J, Suh E, Akhtar R . Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study. J Parkinsons Dis. 2021; 11(2):757-765. PMC: 8058284. DOI: 10.3233/JPD-202406. View

Ma H, Brosens L, Offerhaus G, Giardiello F, de Leng W, Montgomery E . Pathology and genetics of hereditary colorectal cancer. Pathology. 2017; 50(1):49-59. DOI: 10.1016/j.pathol.2017.09.004. View

Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R . Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med. 2004; 351(19):1972-7. DOI: 10.1056/NEJMoa033277. View

Birch P, Adam S, Bansback N, Coe R, Hicklin J, Lehman A . DECIDE: a Decision Support Tool to Facilitate Parents' Choices Regarding Genome-Wide Sequencing. J Genet Couns. 2016; 25(6):1298-1308. DOI: 10.1007/s10897-016-9971-8. View

. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018; 17(11):939-953. PMC: 6191528. DOI: 10.1016/S1474-4422(18)30295-3. View

10.

Mullin S, Smith L, Lee K, DSouza G, Woodgate P, Elflein J . Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial. JAMA Neurol. 2020; 77(4):427-434. PMC: 6990847. DOI: 10.1001/jamaneurol.2019.4611. View

11.

Valente E, Bentivoglio A, Dixon P, Ferraris A, Ialongo T, Frontali M . Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet. 2001; 68(4):895-900. PMC: 1275643. DOI: 10.1086/319522. View

12.

Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S . Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature. 1998; 392(6676):605-8. DOI: 10.1038/33416. View

13.

Falcone D, Wood E, Xie S, Siderowf A, Van Deerlin V . Genetic testing and Parkinson disease: assessment of patient knowledge, attitudes, and interest. J Genet Couns. 2011; 20(4):384-95. PMC: 3280083. DOI: 10.1007/s10897-011-9362-0. View

14.

Harris P, Taylor R, Minor B, Elliott V, Fernandez M, ONeal L . The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019; 95:103208. PMC: 7254481. DOI: 10.1016/j.jbi.2019.103208. View

15.

Sidransky E, Lopez G . The link between the GBA gene and parkinsonism. Lancet Neurol. 2012; 11(11):986-98. PMC: 4141416. DOI: 10.1016/S1474-4422(12)70190-4. View

16.

Adam S, Birch P, Coe R, Bansback N, Jones A, Connolly M . Assessing an Interactive Online Tool to Support Parents' Genomic Testing Decisions. J Genet Couns. 2018; . DOI: 10.1007/s10897-018-0281-1. View

17.

Polymeropoulos M, Lavedan C, Leroy E, Ide S, Dehejia A, Dutra A . Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science. 1997; 276(5321):2045-7. DOI: 10.1126/science.276.5321.2045. View

18.

Cook L, Schulze J, Kopil C, Hastings T, Naito A, Wojcieszek J . Genetic Testing for Parkinson Disease: Are We Ready?. Neurol Clin Pract. 2021; 11(1):69-77. PMC: 8101316. DOI: 10.1212/CPJ.0000000000000831. View

19.

Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

20.

Bonifati V, Rizzu P, Squitieri F, Krieger E, Vanacore N, van Swieten J . DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism. Neurol Sci. 2003; 24(3):159-60. DOI: 10.1007/s10072-003-0108-0. View